Term ends Feb 13, 2035 · Medium confidence
20-year base term ends Feb 13, 2035
Why Medium: The disclaimer's references carry disclaimers of their own not yet read (US 10,045,980), so the cap could be lower.
Feb 13, 2015
Feb 13, 2035
Oct 27, 2020
This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. 1 of 3 maintenance fees is paid so far. Confidence: Medium. from the record
How we calculated this date
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Feb 13, 2015, when application 14/622,368, the earliest non-provisional in its chain, was filed (this one was filed Jul 11, 2018) | Feb 13, 2035 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 10,045,980, US 10,294,216, US 9,447,076, US 9,884,845) | resolves to Feb 13, 2035, no earlier than this term, so no change | Medium confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 1 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Feb 13, 2035 | Medium confidence |
This family
| US 9,447,076 | In force Feb 2035 | Feb 2035 |
| US 9,624,196 | In force Feb 2035 | Feb 2035 |
| US 10,045,980 | In force no later than Feb 2035 | no later than Feb 2035 |
| US 10,815,217 | this patent Feb 2035 | Feb 2035 |
| US 11,634,406 | In force Feb 2035 | Feb 2035 |
Assignments
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Jun 12, 2019 Reel 49444, frame 484 | Longshaw, Alistair Ian; Fraser Fordyce, Euan Alexander; Onions, Stuart Thomas; King-underwood, John; Venable, Jennifer | Respivert Ltd.; Topivert Pharma Ltd. | Assignment of Assignor's Interest |
| Jun 12, 2019 Reel 49444, frame 532 | Topivert Pharma Limited | Respivert Limited | Assignment of Assignor's Interest |
| Jun 12, 2019 reel/frame not recorded | Venable, Jennifer; King-underwood, John; Longshaw, Alistair Ian; Onions, Stuart Thomas; Fraser Fordyce, Euan Alexander | Respivert Ltd. | Assignment of Assignor's Interest |
| Jun 12, 2019 reel/frame not recorded | Venable, Jennifer; King-underwood, John; Longshaw, Alistair Ian; Onions, Stuart Thomas; Fraser Fordyce, Euan Alexander | Topivert Pharma Ltd. | Assignment of Assignor's Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
A terminal disclaimer resolved from the filed document, referencing US 10,045,980, US 10,294,216, US 9,447,076, US 9,884,845, ends no earlier than this term, so it caps nothing.